Cambridge Startups Gain Seoul-Incheon Launch Route
The third Leaps landing spot extends Cambridge's international model to Asia, with 11 companies already participating.
Updated on Nov. 6, 2026 in Startups
Cambridge Enterprise has announced Seoul-Incheon as the third landing spot for its Leaps initiative, joining London and New York. The program embeds Cambridge-based companies in complementary ecosystems abroad, and eleven companies have already joined; the expansion is announced rather than a completed set of results.
Why it matters
The initiative gives Cambridge-born companies a structured route into three international innovation hubs, with access to new markets, talent and investment. Its expansion to Seoul-Incheon signals a deliberate push to build cross-border collaboration as a growth model for university-linked startups.
The program currently counts 11 participating companies across three landing spots, a figure reported as already joined rather than as a performance result. No funding, revenue or survival data for participants was provided, so the scale of the initiative's effect cannot yet be measured.
The players
Cambridge Enterprise
The commercialization arm of the University of Cambridge, which runs the Leaps initiative to move university-linked companies into international ecosystems.
CardiaTec Bio
A Songdo-based company that is the first participant in the Seoul-Incheon Leap.
Janus Property Company
A property developer that partnered with Cambridge Enterprise on the New York Leap, which is located in the Janus Factory District in Manhattan.
Yonsei Science Park
A Seoul-area science park that co-runs the Seoul-Incheon Leap alongside iCREATE.
iCREATE
A Japanese innovation-support organization that co-runs the Seoul-Incheon Leap with Yonsei Science Park.
The details
Leaps works by placing Cambridge-based companies inside partner ecosystems in other cities, rather than asking them to relocate entirely. In Seoul-Incheon, the program runs with Yonsei Science Park and iCREATE, and the first participant is CardiaTec Bio, based in Songdo. Companies applied and were selected on a competitive basis by the Leap partners and advisory boards.
Timeline
May of the prior year: a report ranked Cambridge among the world's top cities for innovation output per capita.
November 6, 2026: Cambridge Enterprise announced Seoul-Incheon as the third Leaps landing spot.
The Tech Race
The Seoul-Incheon Leap extends a model Cambridge Enterprise has already built in London and New York, placing it alongside those two existing hubs. It positions Cambridge's university spinouts to compete for Asian market access and talent in the same way the initiative previously targeted Western ecosystems.
Selected Cambridge-born companies gain access to new markets, talent and investment in London, New York and Seoul-Incheon through the program. The source gives no timeline for when participants will see concrete results or any cost to join, so availability beyond selection is unannounced.
The takeaway
Watch whether the Seoul-Incheon Leap, starting with CardiaTec Bio, produces named company milestones that can be compared against the London and New York cohorts. The count of 11 participating companies is the baseline to track as the program grows.
Further reading
For broader context on how university-backed companies scale across borders, explore our Startups coverage.
